Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Tirzepatide is a medication that activates both GIP and GLP-1 receptors to enhance insulin secretion, reduce appetite, and slow gastric emptying, leading to significant weight loss and improved blood sugar control
In the Phase 2 trial, elevated pulse rate was observed in some participants receiving retatrutide
Despite research reporting physiological potential similar to the parent protein, Receptor Grade IGF-1 LR3 does not appear to interact with IGF binding proteins (IGFBPs) as strongly as IGF-1
Because gastrointestinal adverse events usually limit dosing across this drug class
Oral administration is most relevant for GI-focused applications
US$ 28.51
US$ 20.48
US$ 24.51
US$ 22.55
US$ 24.01
